The involvement of TGF-β1-induced non-canonical MAPK signaling (e.g., ERK-, c-Jun-, or p38-dependent) in the progression of cardiac, liver, kidney, or lung fibrosis was described previously [14,21,23,25,26,27]. Here, TGFB1 is linked to pulmonary fibrosis.